Kala Pharmaceuticals

Kala Pharmaceuticals is developing new therapies for the treatment of mucosal tissue diseases. The company's proprietary Mucus Penetrating Particles technology significantly improves drug distribution and pharmacokinetics by uniformly coating mucosal surfaces with biocompatible drug-loaded particles. The company’s investigational products have demonstrated successful in vivo proof-of-concept in mucosal organs such as the respiratory tract, eyes, and cervicovaginal area, enabling diversified product opportunities targeting significant unmet clinical needs.